Company page

Affymax Inc

Affymax Inc (ticker: AFFY) is a public company based in the United States, with a market capitalization of approximately $37.49 million. The company is focused on developing innovative therapies for patients with serious medical conditions. Affymax is committed to advancing its research and development efforts to improve patient outcomes.